Correlation Between Centum Electronics and Biofil Chemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centum Electronics and Biofil Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centum Electronics and Biofil Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centum Electronics Limited and Biofil Chemicals Pharmaceuticals, you can compare the effects of market volatilities on Centum Electronics and Biofil Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centum Electronics with a short position of Biofil Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centum Electronics and Biofil Chemicals.

Diversification Opportunities for Centum Electronics and Biofil Chemicals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Centum and Biofil is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Centum Electronics Limited and Biofil Chemicals Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofil Chemicals Pha and Centum Electronics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centum Electronics Limited are associated (or correlated) with Biofil Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofil Chemicals Pha has no effect on the direction of Centum Electronics i.e., Centum Electronics and Biofil Chemicals go up and down completely randomly.

Pair Corralation between Centum Electronics and Biofil Chemicals

Assuming the 90 days trading horizon Centum Electronics Limited is expected to generate 1.01 times more return on investment than Biofil Chemicals. However, Centum Electronics is 1.01 times more volatile than Biofil Chemicals Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Biofil Chemicals Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest  148,045  in Centum Electronics Limited on November 8, 2024 and sell it today you would earn a total of  33,400  from holding Centum Electronics Limited or generate 22.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Centum Electronics Limited  vs.  Biofil Chemicals Pharmaceutica

 Performance 
       Timeline  
Centum Electronics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Centum Electronics Limited are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Centum Electronics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Biofil Chemicals Pha 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biofil Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Centum Electronics and Biofil Chemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centum Electronics and Biofil Chemicals

The main advantage of trading using opposite Centum Electronics and Biofil Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centum Electronics position performs unexpectedly, Biofil Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofil Chemicals will offset losses from the drop in Biofil Chemicals' long position.
The idea behind Centum Electronics Limited and Biofil Chemicals Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities